Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview

Baudax Bio

31/10/2022 18:35

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on November 2
(estimated). 
    * The Malvern Pennsylvania-based  company is expected to
report  a
243.4% increase in revenue to $965 thousand from $281 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for a
loss of 53 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$2​, above​ its last closing price of $0.20. ​​​

This summary was machine generated October 31 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated